ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

REPL Replimune Group Inc

8.365
-1.10 (-11.58%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Replimune Group Inc REPL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-1.10 -11.58% 8.365 06:44:20
始値 安値 高値 終値 前日終値
9.43 8.315 9.5495 8.365 9.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1321:36EDGAR2Form 8-K - Current report
2024/6/1321:30GLOBEReplimune Announces $100 Million Private Placement Financing
2024/6/1109:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0805:51EDGAR2Form 144 - Report of proposed sale of securities
2024/6/0721:00GLOBEReplimune to Present at the Goldman Sachs 45th Annual Global..
2024/6/0622:15EDGAR2Form 8-K - Current report
2024/6/0620:00GLOBEReplimune Announces Positive Topline Primary Analysis Data..
2024/6/0322:27EDGAR2Form 8-K - Current report
2024/6/0321:00GLOBEReplimune Presents Positive Data from RP1 and RP2 Clinical..
2024/5/2406:00GLOBEReplimune to Present at the 2024 American Society of..
2024/5/2405:17EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2109:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2109:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2109:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2109:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1622:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/5/1622:07EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/5/1621:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/5/1621:11EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
2024/5/1621:08EDGAR2Form 8-K - Current report
2024/5/1621:00GLOBEReplimune Reports Fiscal Fourth Quarter and Year Ended 2024..
2024/4/0806:00GLOBEInterim Results from the ARTACUS Clinical Trial of RP1..
2024/4/0421:00GLOBEReplimune Announces Inducement Grants Under Nasdaq Listing..
2024/3/2620:30GLOBEReplimune Announces Appointment of Sushil Patel to CEO and..
2024/3/0622:00GLOBEReplimune to Present at the American Association for Cancer..
2024/3/0522:00GLOBEReplimune to Present at Three Upcoming Investor Conferences
2024/2/1421:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/0822:05EDGAR2Form 8-K - Current report
2024/2/0822:00GLOBEReplimune Reports Fiscal Third Quarter 2024 Financial..
2024/1/1618:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
2024/1/1617:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
2024/1/0822:00EDGAR2Form 8-K - Current report
2023/12/2822:00GLOBEReplimune to Present at the 42nd Annual J.P. Morgan..
2023/12/2707:15EDGAR2Form 8-K - Current report
2023/12/0521:19EDGAR2Form 8-K - Current report
2023/12/0521:00GLOBEReplimune Shares Initial Primary Analysis Results from..
2023/11/1810:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1810:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0823:10GLOBEReplimune Presents Updated Data on RP2 in Uveal Melanoma..
2023/11/0807:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0722:15EDGAR2Form 8-K - Current report
2023/11/0722:00GLOBEReplimune Reports Fiscal Second Quarter 2024 Financial..
2023/11/0408:30GLOBEReplimune Presents Updated Interim Results from the ARTACUS..
2023/9/2109:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2109:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/2005:01GLOBEReplimune Announces Inducement Grants Under Nasdaq Listing..
2023/9/1921:15EDGAR2Form 8-K - Current report
2023/9/1921:00GLOBEReplimune Announces Appointment of Emily Hill as Chief..
2023/9/1410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock